Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 27

1.

Rodent Models of Non-classical Progesterone Action Regulating Ovulation.

Mittelman-Smith MA, Rudolph LM, Mohr MA, Micevych PE.

Front Endocrinol (Lausanne). 2017 Jul 24;8:165. doi: 10.3389/fendo.2017.00165. eCollection 2017. Review.

2.

Membrane Associated Progesterone Receptors: Promiscuous Proteins with Pleiotropic Functions - Focus on Interactions with Cytochromes P450.

Ryu CS, Klein K, Zanger UM.

Front Pharmacol. 2017 Mar 27;8:159. doi: 10.3389/fphar.2017.00159. eCollection 2017. Review.

3.

Ligand and Target Discovery by Fragment-Based Screening in Human Cells.

Parker CG, Galmozzi A, Wang Y, Correia BE, Sasaki K, Joslyn CM, Kim AS, Cavallaro CL, Lawrence RM, Johnson SR, Narvaiza I, Saez E, Cravatt BF.

Cell. 2017 Jan 26;168(3):527-541.e29. doi: 10.1016/j.cell.2016.12.029. Epub 2017 Jan 19.

4.

Genome-wide analyses of chitin synthases identify horizontal gene transfers towards bacteria and allow a robust and unifying classification into fungi.

Gonçalves IR, Brouillet S, Soulié MC, Gribaldo S, Sirven C, Charron N, Boccara M, Choquer M.

BMC Evol Biol. 2016 Nov 24;16(1):252.

5.

PGRMC1 Elevation in Multiple Cancers and Essential Role in Stem Cell Survival.

Hampton KK, Stewart R, Napier D, Claudio PP, Craven RJ.

Adv Lung Cancer (Irvine). 2015 Sep;4(3):37-51. Epub 2016 Jan 28.

6.

Progesterone Receptor Membrane Component 1 Mediates Progesterone-Induced Suppression of Oocyte Meiotic Prophase I and Primordial Folliculogenesis.

Guo M, Zhang C, Wang Y, Feng L, Wang Z, Niu W, Du X, Tang W, Li Y, Wang C, Chen Z.

Sci Rep. 2016 Nov 16;6:36869. doi: 10.1038/srep36869.

7.

A Novel Role for Progesterone Receptor Membrane Component 1 (PGRMC1): A Partner and Regulator of Ferrochelatase.

Piel RB 3rd, Shiferaw MT, Vashisht AA, Marcero JR, Praissman JL, Phillips JD, Wohlschlegel JA, Medlock AE.

Biochemistry. 2016 Sep 20;55(37):5204-17. doi: 10.1021/acs.biochem.6b00756. Epub 2016 Sep 9.

8.

PGRMC1 regulation by phosphorylation: potential new insights in controlling biological activity

Cahill MA, Jazayeri JA, Kovacevic Z, Richardson DR.

Oncotarget. 2016 Aug 9;7(32):50822-50827. doi: 10.18632/oncotarget.10691.

9.

Haem-dependent dimerization of PGRMC1/Sigma-2 receptor facilitates cancer proliferation and chemoresistance.

Kabe Y, Nakane T, Koike I, Yamamoto T, Sugiura Y, Harada E, Sugase K, Shimamura T, Ohmura M, Muraoka K, Yamamoto A, Uchida T, Iwata S, Yamaguchi Y, Krayukhina E, Noda M, Handa H, Ishimori K, Uchiyama S, Kobayashi T, Suematsu M.

Nat Commun. 2016 Mar 18;7:11030. doi: 10.1038/ncomms11030.

10.

Spectroscopic and mutagenesis studies of human PGRMC1.

Kaluka D, Batabyal D, Chiang BY, Poulos TL, Yeh SR.

Biochemistry. 2015 Mar 3;54(8):1638-47. doi: 10.1021/bi501177e. Epub 2015 Feb 23.

11.

Role of protein-protein interactions in cytochrome P450-mediated drug metabolism and toxicity.

Kandel SE, Lampe JN.

Chem Res Toxicol. 2014 Sep 15;27(9):1474-86. doi: 10.1021/tx500203s. Epub 2014 Aug 29. Review.

12.

Progesterone receptor membrane component 1 is a functional part of the glucagon-like peptide-1 (GLP-1) receptor complex in pancreatic β cells.

Zhang M, Robitaille M, Showalter AD, Huang X, Liu Y, Bhattacharjee A, Willard FS, Han J, Froese S, Wei L, Gaisano HY, Angers S, Sloop KW, Dai FF, Wheeler MB.

Mol Cell Proteomics. 2014 Nov;13(11):3049-62. doi: 10.1074/mcp.M114.040196. Epub 2014 Jul 20.

13.

Therapeutic targeting of pancreatic cancer utilizing sigma-2 ligands.

Hornick JR, Spitzer D, Goedegebuure P, Mach RH, Hawkins WG.

Surgery. 2012 Sep;152(3 Suppl 1):S152-6. doi: 10.1016/j.surg.2012.05.014. Epub 2012 Jul 3. Review.

14.

Neutrophil gelatinase-associated lipocalin (NGAL) expression is dependent on the tumor-associated sigma-2 receptor S2RPgrmc1.

Mir SU, Jin L, Craven RJ.

J Biol Chem. 2012 Apr 27;287(18):14494-501. doi: 10.1074/jbc.M111.324921. Epub 2012 Mar 14.

15.

Cloning, mapping and molecular characterization of porcine progesterone receptor membrane component 2 (PGRMC2) gene.

Chen C, Sargent C, Quilter C, Yang Z, Ren J, Affara N, Brenig B, Huang L.

Genet Mol Biol. 2010 Jul;33(3):471-4. doi: 10.1590/S1415-47572010005000057. Epub 2010 Sep 1.

16.
17.

Constitutively overexpressed 21 kDa protein in Hodgkin lymphoma and aggressive non-Hodgkin lymphomas identified as cytochrome B5b (CYB5B).

Murphy D, Parker J, Zhou M, Fadlelmola FM, Steidl C, Karsan A, Gascoyne RD, Chen H, Banerjee D.

Mol Cancer. 2010 Jan 26;9:14. doi: 10.1186/1476-4598-9-14.

18.

Chitin in diatoms and its association with the cell wall.

Durkin CA, Mock T, Armbrust EV.

Eukaryot Cell. 2009 Jul;8(7):1038-50. doi: 10.1128/EC.00079-09. Epub 2009 May 8.

19.

Proteomic expression signature distinguishes cancerous and nonmalignant tissues in hepatocellular carcinoma.

Lee NP, Chen L, Lin MC, Tsang FH, Yeung C, Poon RT, Peng J, Leng X, Beretta L, Sun S, Day PJ, Luk JM.

J Proteome Res. 2009 Mar;8(3):1293-303. doi: 10.1021/pr800637z.

20.

PGRMC1: a new biomarker for the estrogen receptor in breast cancer.

Craven RJ.

Breast Cancer Res. 2008;10(6):113. doi: 10.1186/bcr2191. Epub 2008 Nov 24.

Supplemental Content

Support Center